This is an intermediate-size expanded access protocol to provide ONC201 to patients with H3 K27M-mutant and/or midline gliomas who cannot access ONC201 through clinical trials.
Inclusions/Exclusions: PD by RANO required.
Intermediate-size Expanded Access to ONC201 for Patients with H3 K27M-mutant and/or Midline Gliomas
Schedule An Appointment
Saint John's: A Legacy of Care Excellence - 30 Major Healthcare Awards for 2022 and 2023